Hareedy et al. [15] hypothesized that desethyl HCQ could be primarily responsible for the actions of HCQ, therefore the rate of its formation via CYP2D6 and other CYP enzymes could modify COVID-19 status among HCQ receivers for rheumatoid arthritis. This evidence concerns the gene CYP2D6 and COVID-19.